Authors: Matthew Le Merle, Gail Maderis, Tara Churik, and Charlie Beever on behalf of BayBio

Emerging life science companies and large pharmaceutical firms have much to gain from outsourcing clinical development programs. The industry is increasingly turning to outside clinical research organizations (CROs) to provide specific capabilities and added capacity when needed. Clinical development outsourcing is likely to continue to grow and spread to different parts of the globe as drugmakers seek long-term strategic partnerships with outsourcers, including IT providers.

Download PDF